World Journal of Cardiovascular Diseases

Vol.2 No.4(2012), Paper ID 23703, 9 pages

DOI:10.4236/wjcd.2012.24042

 

The rationale and design of the minocycline plus amiodarone versus amiodarone alone (MINAA) trial for the prevention of atrial fibrillation after cardiac surgery

 

Abdallah Khaled Alameddine, Paul Visintainer, Victor Alimov, Jennifer Germain, Yvonne A. Alameddine, Daniel Engelman, John A. Rousou

 

Divisions of Cardiac Surgery, Baystate Medical Center, Springfield, USA
The Department of Epidemiology and Academic Affairs, Springfield, USA
Divisions of Cardiac Surgery, Baystate Medical Center, Springfield, USA
Divisions of Cardiac Surgery, Baystate Medical Center, Springfield, USA
Divisions of Cardiac Surgery, Baystate Medical Center, Springfield, USA
Divisions of Cardiac Surgery, Baystate Medical Center, Springfield, USA
Divisions of Cardiac Surgery, Baystate Medical Center, Springfield, USA

 

Copyright © 2012 Abdallah Khaled Alameddine, Paul Visintainer, Victor Alimov, Jennifer Germain, Yvonne A. Alameddine, Daniel Engelman, John A. Rousou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Alameddine, A. , Visintainer, P. , Alimov, V. , Germain, J. , Alameddine, Y. , Engelman, D. and Rousou, J. (2012) The rationale and design of the minocycline plus amiodarone versus amiodarone alone (MINAA) trial for the prevention of atrial fibrillation after cardiac surgery. World Journal of Cardiovascular Diseases, 2, 269-276. doi: 10.4236/wjcd.2012.24042.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.